Dr. DiGiovanna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Howard Ave
Yale Physicians Building 2ND floor
New Haven, CT 06519Phone+1 203-688-4191Fax+1 203-737-2617
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 1995 - 1997- Yale-New Haven Medical CenterResidency, Internal Medicine, 1991 - 1993
Yale School of MedicineClass of 1990
Certifications & Licensure
CT State Medical License 1993 - 2025
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
Publications & Presentations
PubMed
- PTEN inactivating mutations are associated with hormone receptor loss during breast cancer recurrence.Haiying Zhan, Vijay Mariadas Antony, Haiming Tang, Janie Theriot, Yuanxin Liang
Breast Cancer Research and Treatment. 2025-03-10 - 2 citationsTrends in breast cancer-specific death by clinical stage at diagnoses between 2000 and 2017.Michal Marczyk, Adriana Kahn, Andrea Silber, Mariya Rosenblit, Michael P Digiovanna
Journal of the National Cancer Institute. 2025-02-01 - 2 citationsSurvival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer.Charles E Geyer Jr, Michael Untch, Chiun-Sheng Huang, Max S Mano, Eleftherios P Mamounas
The New England Journal of Medicine. 2025-01-16
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
